News September 20, 2022
BURLINGTON, Mass. and JERUSALEM, Sept. 20, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
News September 14, 2022
Cigna® Issues Favorable Policy for Deep TMS to Address Medication-Resistant Obsessive-Compulsive Disorder BURLINGTON,...
News August 31, 2022
BURLINGTON, Mass. and JERUSALEM, August 31, 2022 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...
Events September 24, 2022
BrainsWay is attending NAMIWalks Your Way (National Alliance on Mental Illness) on September 24, 2022,...
Events September 25, 2022
BrainsWay is attending NAMIWalks Your Way (National Alliance on Mental Illness) on September 25, 2022,...
Events October 1, 2022
BrainsWay is attending NAMIWalks Your Way (National Alliance on Mental Illness) on October 1, 2022, at...
In the media September 16, 2022
Policy change by Cigna to now begin covering Deep TMS for the treatment of obsessive-compulsive disorder,...
In the media August 26, 2022
Story featuring insights from four CEOs (including BrainsWay’s CEO, Dr. Christopher von Jako) about...
In the media August 22, 2022
Patient Lori Jackson details her history of depression, her unsuccessful treatments with medication,...
